Grifols Egypt key moments and significant milestones achieved during 2023

Grifols Egypt's key moments that encapsulate the unwavering commitment and hard work exhibited by GEPD team throughout the year, leading to remarkable accomplishments that set the stage for continued success in the future.

Grifols Egypt CEO, Dr. Magdy Amin and Anita Brikman, President & CEO Plasma Protein Therapeutics Association (PPTA) on the significance of IQPP certification and GEPD's contribution to providing sustainable access of plasma derived medicines in Egypt

Glimpses of GEPD during Africa Health ExCon 2023

H.E. President El Sisi visited GEPD booth at Africa Health ExCon 2023 for the second year in a row

On 6th June 2023,  H.E. President El Sisi visited GEPD booth at Africa Health ExCon 2023. Following an announcement by Dr. Magdy Amin; CEO of GEPD, on the arrival of the first "Human Albumin" derived from the Egyptian plasma from Spain, and a presentation about the project's milestones.

H.E. congratulated GEPD and Egypt’s citizens on the progress made in building a world-class plasma-supply infrastructure to help the country become self-sufficient in essential plasma-derived medicines.

H.E. has visited the GEPD stand in each of the two years that Africa Health ExCon has taken place. 

Grifols Egypt’s first plasma is shipped to Spain for manufacturing into lifesaving medicines

In 2022, thousands of qualified Egyptian donors contributed to plasma donations, which will yield tens of thousands of grams of plasma medicines including immunoglobulin (Ig) and albumin in addition to blood-clotting factors. Those essential medicines are used to treat many rare, chronic, and at times life-threatening conditions such as immunodeficiencies, cardiopulmonary issues,  emergency medicine to treat shock and severe burns, as well as bleeding disorders.